These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30538426)

  • 1. Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway.
    Han J; Shi X; Zheng Z; Zhang B; Shi F; Jiang L; Xu J
    Drug Des Devel Ther; 2018; 12():3985-3997. PubMed ID: 30538426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II-challenged vascular endothelium.
    Han J; Shi X; Du Y; Shi F; Zhang B; Zheng Z; Xu J; Jiang L
    Phytother Res; 2019 Mar; 33(3):779-790. PubMed ID: 30632210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway.
    Wu Y; Li ZC; Yao LQ; Li M; Tang M
    Appl Physiol Nutr Metab; 2019 Jan; 44(1):1-6. PubMed ID: 29742356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2.
    Lin Q; Qin X; Shi M; Qin Z; Meng Y; Qin Z; Guo S
    Int Immunopharmacol; 2017 Aug; 49():142-147. PubMed ID: 28577438
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.
    Kwan HY; Niu X; Dai W; Tong T; Chao X; Su T; Chan CL; Lee KC; Fu X; Yi H; Yu H; Li T; Tse AK; Fong WF; Pan SY; Lu A; Yu ZL
    Sci Rep; 2015 Mar; 5():9114. PubMed ID: 25766252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of cyclosporine A induced nephrotoxicity by schisandrin B through suppression of oxidative stress, apoptosis and autophagy.
    Lai Q; Luo Z; Wu C; Lai S; Wei H; Li T; Wang Q; Yu Y
    Int Immunopharmacol; 2017 Nov; 52():15-23. PubMed ID: 28846887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Schisandrin B on cigarette smoke-induced airway injury in mice through Nrf2 pathway.
    Jia R; Zhang H; Yang Z; Zhao H; Liu F; Wang H; Miao M; Wang Q; Liu Y
    Int Immunopharmacol; 2017 Dec; 53():11-16. PubMed ID: 29031142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
    Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
    J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway.
    Qin JH; Lin JR; Ding WF; Wu WH
    Inflammation; 2019 Jun; 42(3):884-894. PubMed ID: 30519926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schisandrin B elicits the Keap1-Nrf2 defense system via carbene reactive metabolite which is less harmful to mice liver.
    Feng S; Qiu B; Zou L; Liu K; Xu X; Zhu H
    Drug Des Devel Ther; 2018; 12():4033-4046. PubMed ID: 30568426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation.
    Chun JN; Kim SY; Park EJ; Kwon EJ; Bae DJ; Kim IS; Kim HK; Park JK; Lee SW; Park HH; So I; Jeon JH
    J Ethnopharmacol; 2014 Mar; 152(2):364-71. PubMed ID: 24486209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-κB, MAPKs and PI3K/Akt pathways and activating Nrf2/HO-1 signaling.
    Kwon DH; Cha HJ; Choi EO; Leem SH; Kim GY; Moon SK; Chang YC; Yun SJ; Hwang HJ; Kim BW; Kim WJ; Choi YH
    Int J Mol Med; 2018 Jan; 41(1):264-274. PubMed ID: 29115385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin B alleviates diabetic nephropathy through suppressing excessive inflammation and oxidative stress.
    Mou Z; Feng Z; Xu Z; Zhuang F; Zheng X; Li X; Qian J; Liang G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):243-249. PubMed ID: 30477745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedative and hypnotic effects of Schisandrin B through increasing GABA/Glu ratio and upregulating the expression of GABA
    Li N; Liu J; Wang M; Yu Z; Zhu K; Gao J; Wang C; Sun J; Chen J; Li H
    Biomed Pharmacother; 2018 Jul; 103():509-516. PubMed ID: 29677536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
    You S; Qian J; Wu G; Qian Y; Wang Z; Chen T; Wang J; Huang W; Liang G
    Phytomedicine; 2019 Sep; 62():152955. PubMed ID: 31146168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis
    Zhang Q; Liu J; Duan H; Li R; Peng W; Wu C
    J Adv Res; 2021 Dec; 34():43-63. PubMed ID: 35024180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrin B protects human keratinocyte-derived HaCaT cells from tert-butyl hydroperoxide-induced oxidative damage through activating the Nrf2 signaling pathway.
    Ding M; Shu P; Gao S; Wang F; Gao Y; Chen Y; Deng W; He G; Hu Z; Li T
    Int J Mol Med; 2018 Dec; 42(6):3571-3581. PubMed ID: 30272282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schisandrin B attenuates CCl
    Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
    Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.